Over-expression of receptor activator of nuclear factor-κB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty

被引:48
|
作者
Wang, Chen-Ti [1 ,2 ]
Lin, Yu-Tsan [2 ,3 ]
Chiang, Bor-Luen [2 ,3 ]
Lee, Shiou-Shia [2 ,3 ]
Hou, Sheng-Mou [1 ,2 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Orthoped, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 100, Taiwan
关键词
Osteolysis; Arthroplasty; Receptor activator of nuclear factor-kappa B ligand (RANKL); Cytokine; Chemokine; BONE-RESORPTION; OSTEOCLAST DIFFERENTIATION; INTERFACE TISSUE; SYNOVIAL-FLUID; WEAR DEBRIS; OSTEOPROTEGERIN; REPLACEMENT; MACROPHAGES; PROSTHESES; PARTICLES;
D O I
10.1016/j.biomaterials.2009.09.017
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Loosening of total hip arthroplasty (THA) caused by periprosthetic osteolysis induced by ultra-high molecular weight polyethylene (UHMWPE) particles is a major clinical problem. We investigated whether there are differences between loosened THA patients and primary THA patients in (1) receptor activator of nuclear factor-kappa B ligand (RANKL) expression on periprosthetic bone marrow cells; (2) RANKL levels, osteoprotegerin (OPG)/RANKL ratios, the levels of inflammatory cytokines and chemokines in synovial fluid. We used flow cytometric analysis to detect RANKL expression on periprosthetic bone marrow cells. We used enzyme-linked immunoassay and multiplex microsphere-based immunoassay to measure RANKL, OPG, cytokines, and chemokines in synovial fluid. We found loosened THA patients had higher RANKL expression on osteoblastic stromal cells, higher levels of RANKL, interleukin (IL)-6, IL-8, IL-10, interferon-gamma-inducible protein (IP)-10, monocyte chemoattractant protein (MCP)-1, monokine induced by interferon-gamma (MIG), and lower OPG/RANKL ratios in synovial fluid than primary THA patients. There was positive correlation between the levels of IL-6, IL-8, IL-10, IP-10, MCP-1, or MIG and RANKL levels in synovial fluid or RANKL expression on osteoblastic stromal cells. These suggest that UHMWPE particles induce over-expression of RANKL, IL-6, IL-8, IP-10, MCP-1, and MIG in human periprosthetic microenvironment. This results in periprosthetic osteolysis and loosening of THA. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 50 条
  • [41] Role of Prostaglandin E in Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Expression in Osteoblasts Induced by Cell Adhesion to Bone Marrow B-lymphocytes
    Hirata, Michiko
    Harada, Suguru
    Matsumoto, Chiho
    Takita, Morichika
    Miyaura, Chisato
    Inada, Masaki
    JOURNAL OF HEALTH SCIENCE, 2009, 55 (05) : 832 - 837
  • [42] Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand
    Wang, Qing-Ping
    Yang, Li
    Li, Xian-Ping
    Xie, Hui
    Liao, Er-Yuan
    Wang, Min
    Luo, Xiang-Hang
    BONE, 2012, 51 (03) : 515 - 523
  • [43] Determination of three isoforms of the receptor activator of nuclear factor-κB ligand and their differential expression in bone and thymus
    Ikeda, T
    Kasai, M
    Utsuyama, M
    Hirokawa, K
    ENDOCRINOLOGY, 2001, 142 (04) : 1419 - 1426
  • [44] Effect of Triptolide on Expression of Receptor Activator of Nuclear Factor-κB Ligand in Rat Adjuvant Induced Arthritis
    胡永红
    罗波
    张明敏
    涂胜豪
    曾克勤
    华中科技大学学报(医学英德文版), 2006, (03) : 344 - 346
  • [45] Effect of triptolide on expression of receptor activator of nuclear factor-κB ligand in rat adjuvant induced arthritis
    Hu Yonghong
    Luo Bo
    Zhang Mingmin
    Tu Shenghao
    Zeng Keqing
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2006, 26 (3): : 344 - 346
  • [46] In vitro expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin in cultured equine articular cells
    Byron, Christopher R.
    Barger, Anne M.
    Stewart, Allison A.
    Pondenis, Holly C.
    Fan, Timothy M.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2010, 71 (06) : 615 - 622
  • [47] Receptor activator of nuclear factor-κB (RANK) ligand expression:: In human multiple myeloma cells.
    Mitsiades, CS
    Mitsiades, N
    Poulaki, V
    Hayashi, T
    Hideshima, T
    Podar, K
    LeBlanc, R
    Catley, L
    Tai, YT
    Chauhan, D
    Lin, B
    Schlossman, R
    Richardson, PG
    Munshi, N
    Treon, SP
    Anderson, KC
    BLOOD, 2001, 98 (11) : 638A - 638A
  • [48] Structure-based development of a receptor activator of nuclear factor-κB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis
    Ta, Hai Minh
    Nguyen, Giang Thi Tuyet
    Jin, Hye Mi
    Choi, Jongkeun
    Park, Hyejin
    Kim, Nacksung
    Hwang, Hye-Yeon
    Kim, Kyeong Kyu
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (47) : 20281 - 20286
  • [49] Expression of receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin (OPG) in IL-10-/- and, mdr1a-/- mouse models of colitis
    Resta-Lenert, Silvia C.
    Lee, Susan J.
    GASTROENTEROLOGY, 2006, 130 (04) : A548 - A548
  • [50] Development of Small-Molecules Targeting Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Receptor Activator of Nuclear Factor-κB (RANK) Protein-Protein Interaction by Structure-Based Virtual Screening and Hit Optimization
    Jiang, Min
    Peng, Lei
    Yang, Kai
    Wang, Tianqi
    Yan, Xueming
    Jiang, Tao
    Xu, Jianrong
    Qi, Jin
    Zhou, Hanbing
    Qian, Niandong
    Zhou, Qi
    Chen, Bo
    Xu, Xing
    Deng, Lianfu
    Yang, Chunhao
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (11) : 5370 - 5381